Zhejiang Orient Gene Biotech Co., Ltd researches and develops, produces, and sells in vitro diagnostic products in China and internationally. Its products include POCT instant diagnostic reagents that are used for detection of infectious diseases, drugs of abuse, fertility, tumor marker, and cardiac marker detection. The company also offers human and animal health products; and raw materials for rapid testing, fluorescent immunoassay, western blot, biochemistry, and molecular diagnostics. It serves pharmacies chain, supermarkets, tertiary hospitals, healthcare institutions, third-party laboratories, medical distributors, and pharmaceutical distribution clients. Zhejiang Orient Gene Biotech Co., Ltd was incorporated in 2005 and is based in Huzhou, China.
Research context
Zhejiang Orient Gene Biotech Co., Ltd appears in PyInvesting’s Shanghai Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Medical Devices
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Zhejiang Orient Gene Biotech Co., Ltd is currently in a long term uptrend where the price is trading 31.7% above its 200 day moving average.
From a valuation standpoint, the stock is 23.6% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 11.9.
Based on the above factors, Zhejiang Orient Gene Biotech Co., Ltd gets an overall score of 1/5.